Robert Eberwein

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

NewSpring Healthcare is the venture capital/private equity operating health care division of NewSpring Capital LLC founded in 1999. The firm is headquartered in Radnor, Pennsylvania.

Putney, Inc. operates as a veterinary pharmaceutical company which specializes in the development of generic medicine for pets. It offers human-approved generic drugs such as ampicillin sodium for injection, cefpodoxime proxetil tablets and amoxicillin trihydrate capsules. The firm also provides injectables, carprofen caplets and dermatological therapeutics. The company was founded by Jean Hoffman in 2006 and is headquartered in Portland, ME.

Panorama Eye Care LLC is a physician-led management services organization that supports its network of physician clinics through enhanced management of day-to-day business operations. Panorama Eye Care is based in Fort Collins, CO and has subsidiaries in the United States. The organization has 13 locations, over 50 providers, 4 ASCs, and over 500 team members from , WY south through the metro region. The company provides a wide variety of treatment options to address various diseases and conditions related to eye care. The company's mission is to create centers of excellence in eye care by exceeding national benchmarks for clinical quality care, investing in state-of-the-art equipment, providing an unrivaled patient experience, and by focusing on being an employer of choice for their team members within the regions they serve. Marcello J. Celentano has been the CEO of the company since 2021.

Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD

Patheous Health, Inc. engages in the provision of diagnostic and therapeutic services. The company was founded by Michael Peck and Correy Trupp in 2019 and is headquartered in Leawood, KS.

Part of Pfizer Inc., Wyeth BioPharma is a company that develops and manufactures protein biopharmaceuticals. The company is based in Collegeville, PA.

Inhometherapy, Inc. is a company that provides home care providers with a wide range of versatile therapists to extend their reach into more markets. The company is based in King of Prussia, PA and has subsidiaries in the United States. The company has a unique approach that sets it apart from others, and it is the employer of choice for physical, occupational, and speech therapists. Inhome is a highly skilled team of therapists who are redefining how care is delivered to agency partners. The company was founded in 2021, and the CEOs are Matthew Murphy and Matt Murphy.

Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas.

Center For Breakthrough Medicines Holdings LLC is a private company that specializes in gene and cell therapy. The company is based in King of Prussia, PA. The company offers innovative services that are saving lives. The company was founded by Audrey E. Greenberg.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Vybe Urgent Care operates community-based urgent care centers that provide convenient treatment for illnesses and injuries. It offers on-site x-rays, lab tests, vaccinations, and physical exams. The company is headquartered in Philadelphia, PA.

BRC Parent Holdings LLC operates as an investment holding company. The company is headquartered in Wayne, PA.

Vertis, Inc. provides print advertising and direct marketing solutions. The company was founded in 1993 and is headquartered New York, NY.

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

LumaCyte LLC is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation. The company is based in Charlottesville, VA. LumaCyte's revolutionary technology utilizes laser force cytology™ (LFC™) to measure optical and fluidic forces within a microfluidic channel, quantitatively characterizing innate cellular responses of subtle phenotypic changes based purely on the intrinsic biophysical and biochemical properties of cells. The univariate and multivariate nature of the data has enabled a host of big data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell-based biological systems. The company was founded in 2012, and the CEO is Sean J. Hart.

American Aerogel Corp. develops and manufactures aerogel-based insulation products. It provides cold-chain design, implementation, and shipping services. The company was founded by Robert S. Mendenhall, Dennis Young, and Greg R. Andrews in 2013 and is headquartered in Rochester, NY.

Pomona College offers curriculum in the arts, humanities, social sciences and natural sciences. It was founded in 1887 and it is headquartered in Claremont, CA

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies